AzTrials
AzTrials

Edentulous Alveolar RidgeNCT04006782

Narrow Dental Implants in Multiple Fixed Prosthesis: A Controlled Clinical Trial

A study testing Narrow dental implants in people with Edentulous Alveolar Ridge, run by Fundación Eduardo Anitua at 1 site in Spain.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The objective of this study is to evaluate the survival of narrow dental implants (≤ 3,5 mm) in multiple fixed prostheses in comparison with standard diameter dental implants (≥ 3,75 mm) after 5 years of follow-up. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Edentulous Alveolar Ridge
What is being tested?
Narrow dental implants
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
1 siteSpain
Study dates
1 Aug 2019to 31 Jan 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients of legal age (>18 years) of both sexes.
  • Clinical need of multiple fixed alveolar ridge rehabilitations.
  • Clinical suitability to insert, at least, one narrow dental implant splinted to a standard diameter dental implant.
  • Signature of the informed consent

Who cannot join

  • Presence of an active infection
  • Being under active treatment with, or have received in the las 30 days treatment with radiotherapy, chemotherapy, immunosuppressors, systemic corticosteroids and/or anticoagulants.
  • Presence of severe haematologic disorders.
  • Chronic treatment with non steroidal anti-inflammatory drugs (NSAID) or other aniinflammatory drugs.
  • Previous diagnosis of chronic hepatitis or liver cirrhosis.
  • Presence of Diabetes mellitus with improper metabolic control (glycosylated haemoglobine higher that 9%).
Show all 13Show fewer
  • Patients subjected to dialysis.
  • Presence of malignant tumours, haemangioma or angioma in the surgical area.
  • History of ischaemic cardiopathy in the las year.
  • Pregnancy or plan to getting pregnant during the study.
  • Metabolic bone disease
  • Patientd receiving treatment with oral or intravenous biphosphonates.
  • Any other condition incompatible with the participation in the study,

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Clínica Dental Eduardo Anitua

    Vitoria-Gasteiz

Other trials in Spain

About this study

Official title: Narrow Dental Implants in Multiple Fixed Prosthesis

The objective of this study is to evaluate the survival of narrow dental implants (≤ 3,5 mm) in multiple fixed prostheses in comparison with standard diameter dental implants (≥ 3,75 mm) after 5 years of follow-up. The hypothesis of the study is that narrow dental implants under the evaluated conditions, have the same survival rate and clinical performance than the standard diameter implants.

Being tested
Narrow dental implants
Keywords
edentulous, narrow alveolar ridges
Medical subject headings
Mouth, Edentulous

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Narrow dental implantsDevice

    Insertion of narrow dental implants in multiple fixed prosthesis

Study groups in NCT04006782
Study groupRoleWhat they receive
Narrow dental implants in multiple fixed prosthesisOtherNot described
Receives: Device: Narrow dental implants

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Survival after 5 years of follow-up

    Implant survival after 5 years of follow-up

    Measured: 5 years in comparison with the baseline

Secondary outcomes (1)
  1. Marginal Bone Loss

    Evolution of the peri-implant bone level along the study follow up

    Measured: 1, 3 and 5 years in comparison with the baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jul 2019
  2. Study start1 Aug 2019
  3. Primary completion31 Jan 2026 (estimated)
  4. Study completion31 Jan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
48 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04006782
Sponsor's protocol ID
FIBEA_02_EC_19_Estrechos
Status last verified
Feb 2025
First submitted
1 Jul 2019
Last updated
27 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Narrow dental implants in people with Edentulous Alveolar Ridge, run by Fundación Eduardo Anitua at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 27 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Survival after 5 years of follow-up (time frame: 5 years in comparison with the baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in